Mitogen-activated protein kinase signaling pathway in oral cancer (Review)

被引:100
作者
Peng, Qian [1 ]
Deng, Zhiyuan [1 ]
Pan, Hao [1 ]
Gu, Liqun [1 ]
Liu, Ousheng [1 ]
Tang, Zhangui [1 ]
机构
[1] Cent S Univ, Xiangya Stomatol Hosp, 72 Xiangya Rd, Changsha 410008, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
mitogen-activated protein kinase signaling pathway; oral cancer; oral squamous cell carcinoma; kinase; therapeutic targets; inhibitor; treatment; SQUAMOUS-CELL CARCINOMA; MAP KINASE; DIFFERENTIAL REGULATION; COLORECTAL-CANCER; ERK PATHWAY; PROLIFERATION; MODULATION; APOPTOSIS; HEAD; P38;
D O I
10.3892/ol.2017.7491
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The mitogen-activated protein kinase (MAPK) signaling pathway is associated with tumor cell proliferation, differentiation, apoptosis, angiogenesis, invasion and metastasis. The present review assesses the involvement of the MAPK signaling pathway in oral cancer progression and invasion based on analysis of individual sub-pathways and their mechanisms of action. The regulation of this pathway for targeted oral cancer therapy is explored and the challenges confronting this, as well as corresponding potential solutions, are discussed. Exploring this pathway with an emphasis on its components, subfamilies, sub-pathways, interactions with other pathways and clinical practice modes may improve oral cancer treatment.
引用
收藏
页码:1379 / 1388
页数:10
相关论文
共 79 条
[1]   Targeting irradiation-induced mitogen-activated protein kinase activation in vitro and in an ex vivo model for human head and neck cancer [J].
Affolter, Annette ;
Muller, Marie-France ;
Sommer, Katharina ;
Stenzinger, Albrecht ;
Zaoui, Karim ;
Lorenz, Katja ;
Wolf, Thomas ;
Sharma, Sarika ;
Wolf, Janina ;
Perner, Sven ;
Weber, Klaus-Josef ;
Freier, Kolja ;
Plinkert, Peter K. ;
Hess, Jochen ;
Weichert, Wilko .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 :E2049-E2061
[2]  
Aguzzi A, 2009, ANTICANCER RES, V29, P303
[3]   Regulating the regulator: post-translational modification of RAS [J].
Ahearn, Ian M. ;
Haigis, Kevin ;
Bar-Sagi, Dafna ;
Philips, Mark R. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2012, 13 (01) :39-51
[4]   Simvastatin interacts synergistically with tipifarnib to induce apoptosis in leukemia cells through the disruption of RAS membrane localization and ERK pathway inhibition [J].
Ahmed, Tamer A. ;
Hayslip, John ;
Leggas, Markos .
LEUKEMIA RESEARCH, 2014, 38 (11) :1350-1357
[5]   Ell3 stimulates proliferation, drug resistance, and cancer stem cell properties of breast cancer cells via a MEK/ERK-dependent signaling pathway [J].
Ahn, Hee-Jin ;
Kim, Gwangil ;
Park, Kyung-Soon .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 437 (04) :557-564
[6]   Micropackaging via layer-by-layer assembly: microcapsules and microchamber arrays [J].
Antipina, Maria N. ;
Kiryukhin, Maxim V. ;
Skirtach, Andre G. ;
Sukhorukov, Gleb B. .
INTERNATIONAL MATERIALS REVIEWS, 2014, 59 (04) :224-244
[7]   The MAPK Pathway Across Different Malignancies: A New Perspective [J].
Burotto, Mauricio ;
Chiou, Victoria L. ;
Lee, Jung-Min ;
Kohn, Elise C. .
CANCER, 2014, 120 (22) :3446-3456
[8]   Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases [J].
Cargnello, Marie ;
Roux, Philippe P. .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2011, 75 (01) :50-83
[9]   Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma [J].
Carlino, Matteo S. ;
Gowrishankar, Kavitha ;
Saunders, Catherine A. B. ;
Pupo, Gulietta M. ;
Snoyman, Stephanie ;
Zhang, Xu Dong ;
Saw, Robyn ;
Becker, Therese M. ;
Kefford, Richard F. ;
Long, Georgina V. ;
Rizos, Helen .
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (07) :1332-1342
[10]   MEK/ERK signaling pathway in apoptosis of SW620 cell line and inhibition effect of resveratrol [J].
Chen, Hao ;
Jin, Zhi-Liang ;
Xu, Hai .
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2016, 9 (01) :46-50